LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

<<<<

Select the entities to show:

Small molecules	Cells

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF 10A	GSK1059615	0.12	uM	LJP5	1	E05	72	hr	513	7154	10401	0.6878	0.6716
MCF 10A	Geldanamycin	0.12	uM	LJP6	1	O05	72	hr	513	555	10401	0.0534	0.0042
MCF 10A	Geldanamycin	0.12	uM	LJP5	2	O05	72	hr	513	527	10401	0.0507	0.0014
MCF 10A	Pictilisib	0.12	uM	LJP6	2	D23	72	hr	513	3984	10401	0.3830	0.3510
MCF 10A	Geldanamycin	0.12	uM	LJP5	3	O05	72	hr	513	614	10401	0.0590	0.0102
MCF 10A	Gefitinib	0.12	uM	LJP6	3	N11	72	hr	513	2111	10401	0.2030	0.1616
MCF 10A	Geldanamycin	0.12	uM	LJP5	1	O05	72	hr	513	445	10401	0.0428	-0.0069
MCF 10A	Gefitinib	0.12	uM	LJP6	2	N11	72	hr	513	2810	10401	0.2702	0.2323
MCF 10A	Gefitinib	0.12	uM	LJP6	1	N11	72	hr	513	3238	10401	0.3113	0.2756
MCF 10A	Pictilisib	0.12	uM	LJP6	3	D23	72	hr	513	3804	10401	0.3657	0.3328
MCF 10A	Foretinib	0.12	uM	LJP5	3	H11	72	hr	513	10205	10401	0.9811	0.9802
MCF 10A	Pictilisib	0.12	uM	LJP6	1	D23	72	hr	513	3540	10401	0.3404	0.3061
MCF 10A	R406	0.12	uM	LJP6	3	C17	72	hr	513	10023	10401	0.9636	0.9618
MCF 10A	R406	0.12	uM	LJP6	1	C17	72	hr	513	9265	10401	0.8908	0.8851
MCF 10A	R406	0.12	uM	LJP6	2	C17	72	hr	513	9359	10401	0.8998	0.8946
MCF 10A	Foretinib	0.12	uM	LJP5	2	H11	72	hr	513	10341	10401	0.9942	0.9939
MCF 10A	TGX221	0.04	uM	LJP5	2	H24	72	hr	513	9033	10401	0.8685	0.8616
MCF 10A	Erlotinib	0.12	uM	LJP5	3	M23	72	hr	513	8522	10401	0.8193	0.8100
MCF 10A	Fedratinib	0.04	uM	LJP5	1	L06	72	hr	513	10408	10401	1.0007	1.0007
MCF 10A	Fedratinib	0.04	uM	LJP5	2	L06	72	hr	513	10394	10401	0.9993	0.9993